Intervention: Gemcitabine plus nab-Paclitaxel (GnP)
Found 19 matching trials
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
PHASE3
The purpose of this study is to evaluate the efficacy of an investigational...
Status
Recruiting
Location
The University of Arizona Cancer Center-North Campus
A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)
PHASE3
This Phase III randomized trial, evaluates whether adding targeted radiatio...